Literature DB >> 2596324

Intestinal post-ischemic reperfusion injury: studies with neonatal necrotizing enterocolitis.

B H Cassutto1, H P Misra, C J Pfeiffer.   

Abstract

In the feline intestine studies have implicated superoxide (O.-) and other oxygen derived free radicals as initiators of injury as measured by increased capillary permeability during the reperfusion period. Biochemical mechanisms of this free radical generation include: xanthine oxidase dependent O.- production, hydrogen peroxide (H2O2) formation by superoxide dismutase (SOD), hydroxyl radical (OH-) production via the Haber-Weiss reaction, and lipid radical formation from membrane peroxidation. Pathological consequences of these events include inflammatory neutrophil infiltration, damage to the collagen and mucosal basement membrane, increased capillary permeability, edema, cell degeneration and necrosis. Animal models of neonatal necrotizing enterocolitis (NNEC) indicate that intestinal injury occurs after the etiologic factors (hypothermia, hypoxia) are removed. In order to determine the role of active oxygen species in the pathogenesis of NNEC, weanling hamsters and neonatal piglets were cold stressed and activities of pro/antioxidant enzymes were determined, and histopathologic and ultrastructural studies were performed. Cold stressed weanling hamsters showed a 55.7% (P less than 0.05) decrease in xanthine dehydrogenase/xanthine oxidase activity ratio. Light microscopy revealed scattered colonic mucosal erosions and submucosal edema in 50% of cold stressed animals. Transmission electron microscopy demonstrated degeneration of colonic mucosal epithelial cells, enlarged intracellular spaces, cytoplasmic vacuolization, and nuclear membrane swelling. The colonic serosa was also edematous and infiltrated with bacteria. Large intestinal tissue from cold stressed neonatal piglets showed a significant increase (P less than 0.05) in Mn and Cu, Zn, SOD, CAT, GSH-Red, total GSH, and Glc6-PD at 0 and 12 hrs. post stress.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596324

Source DB:  PubMed          Journal:  Acta Physiol Hung        ISSN: 0231-424X


  7 in total

1.  Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges.

Authors:  Peng Lu; Chhinder P Sodhi; Hongpeng Jia; Shahab Shaffiey; Misty Good; Maria F Branca; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

Review 2.  The science and necessity of using animal models in the study of necrotizing enterocolitis.

Authors:  Guillermo J Ares; Steven J McElroy; Catherine J Hunter
Journal:  Semin Pediatr Surg       Date:  2017-11-06       Impact factor: 2.754

Review 3.  Necrotizing enterocolitis: It's not all in the gut.

Authors:  Alissa L Meister; Kim K Doheny; R Alberto Travagli
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

4.  Uric acid is a major antioxidant in human nasal airway secretions.

Authors:  D B Peden; R Hohman; M E Brown; R T Mason; C Berkebile; H M Fales; M A Kaliner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Nitroxide radical attenuates ischaemia/reperfusion injury to the rat small intestine.

Authors:  R Udassin; Y Haskel; A Samuni
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

6.  The Role of the T lymphocytes and Remodeling in Asthma.

Authors:  Kawa Amin
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

Review 7.  The benefits, limitations and opportunities of preclinical models for neonatal drug development.

Authors:  Sarah Campion; Amy Inselman; Belinda Hayes; Costanza Casiraghi; David Joseph; Fabrizio Facchinetti; Fabrizio Salomone; Georg Schmitt; Julia Hui; Karen Davis-Bruno; Karen Van Malderen; LaRonda Morford; Luc De Schaepdrijver; Lutz Wiesner; Stephanie Kourula; Suna Seo; Susan Laffan; Vijay Urmaliya; Connie Chen
Journal:  Dis Model Mech       Date:  2022-04-25       Impact factor: 5.732

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.